MarketCap
Facebook
X
Telegram
Pliant Therapeutics DSO Ratio | PLRX
Annual DSO Ratio Pliant Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 229 | 75 | 272 | 81.7 | - | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 272 | 75 | 164 |
Quarterly DSO Ratio Pliant Therapeutics
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | 897 | 181 | - | 199 | 57 | 119 | - | 97.5 | 102 | 240 | - | 176 | 235 | 25.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 897 | 25.8 | 212 |
DSO Ratio of other stocks in the Biotechnology industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Affimed N.V.
AFMD
|
31.4 | - | -34.95 % | $ 21.5 M |  Germany |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
118 | - | -1.58 % | $ 28.1 M |  China |
 |
Celyad Oncology SA
CYAD
|
64.4 | - | - | $ 12.5 M |  Belgium |
 |
Seer
SEER
|
47.3 | $ 1.62 | -3.57 % | $ 89.7 M |  USA |
 |
Stoke Therapeutics
STOK
|
7.52 | $ 27.16 | -1.98 % | $ 1.61 B | USA |
 |
Sutro Biopharma
STRO
|
22.4 | $ 10.08 | -5.0 % | $ 85.7 M | USA |
 |
Soligenix
SNGX
|
87.4 | $ 0.32 | -6.35 % | $ 1.66 M | USA |
 |
Teva Pharmaceutical Industries Limited
TEVA
|
823 | $ 42.54 | -1.0 % | $ 48.7 B |  Israel |
 |
China SXT Pharmaceuticals
SXTC
|
358 | $ 2.99 | -3.55 % | $ 2.03 M | China |
 |
Takeda Pharmaceutical Company Limited
TAK
|
79.3 | $ 20.9 | -0.9 % | $ 33 B |  Japan |
 |
Supernus Pharmaceuticals
SUPN
|
83.7 | $ 28.77 | 4.15 % | $ 1.62 B | USA |
 |
Galapagos NV
GLPG
|
56.5 | - | - | $ 1.83 B | Belgium |
 |
Savara
SVRA
|
2.41 K | $ 4.92 | -2.57 % | $ 1.09 B | USA |
 |
Teligent, Inc.
TLGT
|
90.7 | - | -13.85 % | $ 16.1 M | USA |
 |
Viela Bio, Inc.
VIE
|
169 | - | - | $ 2.91 B | USA |
 |
TG Therapeutics
TGTX
|
129 | $ 64.27 | 1.4 % | $ 9.28 B | USA |
 |
Aphria Inc.
APHA
|
55.2 | - | -0.45 % | $ 4.87 B |  Canada |
 |
Chiasma, Inc.
CHMA
|
178 | - | -6.00 % | $ 238 M | USA |
 |
Adamas Pharmaceuticals, Inc.
ADMS
|
45.6 | - | - | $ 376 M | USA |
 |
Cerecor Inc.
CERC
|
239 | - | -1.68 % | $ 283 M | USA |
 |
Auris Medical Holding Ltd.
EARS
|
147 | - | -1.77 % | $ 39.2 M |  Bermuda |
 |
Dicerna Pharmaceuticals, Inc.
DRNA
|
80.1 | - | 0.34 % | $ 2.98 B | USA |
 |
ERYTECH Pharma S.A.
ERYP
|
52.8 | - | 1.3 % | $ 27.7 M |  France |
 |
GW Pharmaceuticals plc
GWPH
|
49.3 | - | - | $ 6.81 B | Britain |
 |
Kadmon Holdings, Inc.
KDMN
|
30.6 | - | - | $ 1.7 B | USA |
 |
Liminal BioSciences
LMNL
|
429 | - | - | $ 256 M | Canada |
 |
XBiotech
XBIT
|
40.8 | $ 1.97 | 3.2 % | $ 60.1 M | USA |
 |
Neos Therapeutics, Inc.
NEOS
|
150 | - | -2.54 % | $ 57.2 M | USA |
 |
Osmotica Pharmaceuticals plc
OSMT
|
54.2 | - | -10.74 % | $ 89.9 M | USA |
 |
Pandion Therapeutics, Inc.
PAND
|
0.0395 | - | - | $ 1.77 B | USA |
 |
Xenetic Biosciences
XBIO
|
365 | $ 1.76 | -2.09 % | $ 2.99 M | USA |
 |
Translate Bio, Inc.
TBIO
|
69.9 | - | - | $ 2.81 B | USA |
 |
Trillium Therapeutics Inc.
TRIL
|
2.34 K | - | - | $ 1.94 B | Canada |